Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

Court on yahoo and as the saying goes, would b*tch if he were hung with a new rope.

He continues to harp on when Vitaros will hit the shelves (not our company's decision but Abbott's).

He also wants an update on Femprox phase III. I don't recall in the last several communications from the company that clinical trials were mentioned. What Damaj is focusing on is commercialization. Therefore, it is my opinion that Damaj may be interested in partnering Femprox, getting a pharma to complete the clinical trials and going through the FDA approval process. Apricus would get milestones for phase III startup and/or completion and FDA approval and then double digit royalty fees for sales. If the Pharma is one of the big ones like a Novartis or Abbott, the deal may be for worldwide licensing. Just my opinion but it makes sense to me.